metformin aurobindo 500 mg tabletti, kalvopäällysteinen
aurobindo pharma (malta) ltd - metformini hydrochloridum - tabletti, kalvopäällysteinen - 500 mg - metformiini
metformin aurobindo 850 mg tabletti, kalvopäällysteinen
aurobindo pharma (malta) ltd - metformini hydrochloridum - tabletti, kalvopäällysteinen - 850 mg - metformiini
metformin aurobindo 1000 mg tabletti, kalvopäällysteinen
aurobindo pharma (malta) ltd - metformini hydrochloridum - tabletti, kalvopäällysteinen - 1000 mg - metformiini
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, tyyppi 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.
vipdomet
takeda pharma a/s - alogliptiini bentsoaatti, metformiinihydrokloridia - diabetes mellitus, tyyppi 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. kolmen lääkkeen yhdistelmähoito) ruokavalion lisänä ja liikunta parantaa glukoositasapainoa potilailla, kun insuliinin vakaalla annoksella ja metformiini eivät yksin tarjoa riittävää glukoositasapainoa.
metformin teva 850 mg tabletti, kalvopäällysteinen
teva sweden ab - metformini hydrochloridum - tabletti, kalvopäällysteinen - 850 mg - metformiini
metformin teva 1000 mg tabletti, kalvopäällysteinen
teva sweden ab - metformini hydrochloridum - tabletti, kalvopäällysteinen - 1000 mg - metformiini
metformin orifarm 500 mg tabletti, kalvopäällysteinen
orifarm generics a/s orifarm generics a/s - metformini hydrochloridum - tabletti, kalvopäällysteinen - 500 mg - metformiini
metformin orifarm 850 mg tabletti, kalvopäällysteinen
orifarm generics a/s orifarm generics a/s - metformini hydrochloridum - tabletti, kalvopäällysteinen - 850 mg - metformiini
metformin orifarm 1000 mg tabletti, kalvopäällysteinen
orifarm generics a/s orifarm generics a/s - metformini hydrochloridum - tabletti, kalvopäällysteinen - 1000 mg - metformiini